FDA Approves Boston Scientific’s SYNERGY BP Stent For High Bleeding Risk Patients

The bioabsorbable polymer-coated, sirolimus-eluting stent is the first drug-eluting stent approved for this population.

Sep 16, 2019 Fremont / CA / USA - Boston Scientific office buildings in Silicon Valley; Boston Scientific Corporation is a manufacturer of medical devices used in interventional medical specialties
• Source: shutterstock.com

More from United States

More from North America